TG THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Tg Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Tg Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 156M shares, a 2.86% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 156M +4.33M +2.86% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 155M +3.9M +2.59% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 155M +5.17M +3.46% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 151M +5.04M +3.44% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 151M +6.09M +4.19% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 151M +5.77M +3.98% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 149M +4.85M +3.36% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 146M +3.13M +2.19% Dec 31, 2022 10-K 2024-02-29
Q3 2022 145M +2.41M +1.69% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 145M +2.32M +1.63% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 145M +3.06M +2.17% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 143M +2.67M +1.9% Dec 31, 2021 10-K 2023-03-01
Q3 2021 143M +14M +10.9% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 143M +16.2M +12.8% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 141M +31.3M +28.4% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 141M +31.2M +28.5% Dec 31, 2020 10-K 2022-03-01
Q3 2020 129M +32.3M +33.4% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 127M +33.3M +35.7% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 110M +21.6M +24.4% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 109M +25.5M +30.4% Dec 31, 2019 10-K 2021-03-01
Q3 2019 96.6M +13.7M +16.5% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 93.4M +10.9M +13.2% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 88.5M +11.4M +14.8% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 83.9M +10.7M +14.7% Dec 31, 2018 10-K 2020-03-02
Q3 2018 82.9M +12.3M +17.4% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 82.5M +14.4M +21.2% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 77.1M +10.3M +15.5% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 73.1M +16.4M +28.8% Dec 31, 2017 10-K 2019-03-01
Q3 2017 70.7M +15.9M +29.1% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 68.1M +13.6M +25% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 66.8M +12.7M +23.5% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 56.8M +2.73M +5.04% Dec 31, 2016 10-K 2018-03-15
Q3 2016 54.7M +2.21M +4.2% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 54.5M +2.8M +5.42% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 54.1M +6.65M +14% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 54.1M +9.12M +20.3% Dec 31, 2015 10-K 2017-03-16
Q3 2015 52.5M +11.1M +26.7% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 51.7M +13.5M +35.5% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 47.4M +9.95M +26.5% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 44.9M +10.6M +31% Dec 31, 2014 10-K 2016-03-15
Q3 2014 41.4M +8.04M +24.1% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 38.1M +11.4M +42.7% Jun 30, 2014 10-Q 2014-07-24
Q1 2014 37.5M +11.2M +42.4% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 34.3M +8.49M +32.9% Dec 31, 2013 10-K 2015-03-16
Q3 2013 33.4M +13.3M +66.5% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 26.7M +8.67M +48% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 26.3M +21.3M +420% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 25.8M +20.7M +410% Dec 31, 2012 10-K 2014-03-07
Q3 2012 20.1M +12.7M +171% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 18.1M +15.5M +595% Jun 30, 2012 10-Q/A 2012-09-07
Q1 2012 5.06M Mar 31, 2012 10-Q 2012-05-14
Q4 2011 5.06M +2.64M +109% Dec 31, 2011 10-K 2013-03-21
Q3 2011 7.4M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 2.6M Jun 30, 2011 10-Q/A 2011-09-14
Q4 2010 2.42M Dec 31, 2010 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.